Barometer Capital Management Inc. Dexcom Inc Transaction History

Barometer Capital Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $725,297 - $889,635	6,350 New	6,350 $809 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $365,527 - $425,684	3,250 New	3,250 $418 Million
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $351,000 - $470,250	-4,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $429,795 - $508,275	4,500 New	4,500 $1.86 Billion

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Barometer Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Barometer Capital Management Inc. with notifications on news.